Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CLYYF - IPO Update: Nkarta Proposes Terms For $150 Million IPO


CLYYF - IPO Update: Nkarta Proposes Terms For $150 Million IPO

Quick Take

Nkarta (NKTX) intends to raise $150 million in an IPO of its common stock, according to an amended registration statement.

The company is advancing a pipeline of drug candidates for the treatment of blood and other cancer indications.

NKTX is still at preclinical stage of development for its pipeline, so the IPO is likely more relevant to institutional investors with a long-term hold time frame.

Company & Technology

South San Francisco, California-based Nkarta was founded to engineer what it calls natural killer [NK] cell therapies to treat blood and other

Read more ...

Stock Information

Company Name: Celyad SA
Stock Symbol: CLYYF
Market: OTC
Website: celyad.com

Menu

CLYYF CLYYF Quote CLYYF Short CLYYF News CLYYF Articles CLYYF Message Board
Get CLYYF Alerts

News, Short Squeeze, Breakout and More Instantly...